Tri-lo-mili Kit
Product Images NDC 65862-778

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tri-lo-mili (NDC 65862-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Pack Label (Norgestimate Fig1)

FDA Label Image

Day Label Sticker (Norgestimate Fig2)

FDA Label Image

Pregnancy Chart (Norgestimate Fig3)

FDA Label Image

Blister Pack Label1 (Norgestimate Fig4)

Blister Pack Label1 (Norgestimate Fig4)
This text describes different methods of birth control, including some statistics on pregnancy rates. It indicates that using certain devices, such as implants or diaphragms, and hormonal methods, such as birth control pills, patches, and vaginal rings, can lead to fewer pregnancies per 100 women in one year. Other methods, such as using condoms, having sex during the most fertile days of the monthly cycle, or relying on withdrawal, may result in more pregnancies. The text also mentions potential risks or side effects associated with different birth control methods, such as infections, irritation, or sterilization.*
FDA Label Image

Day Label Sticker1 (Norgestimate Fig5)

FDA Label Image

Package Label-principal Display Panel (Blister Pouch Label)

Package Label-principal Display Panel (Blister Pouch Label)
This is a label template that includes a correctday label with options for MON_TUE, WED, THU, FRI, SAT, and SUN. It also includes color options in shades of white, pale blue, blue, and green with corresponding measurements in milligrams. There is also a section for Peel and Place label application.*
FDA Label Image

Package Label-principal Display Panel (Pouch Carton)

Package Label-principal Display Panel (Pouch Carton)
Tri-Lo-Mili is a medication in the form of tablets that contains norgestimate and ethinyl estradiol. It comes in different dosages, including 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The package contains 28 tablets and, like all oral contraceptives, is not intended to protect against HIV infection. The manufacturer is Aurobindo.*
FDA Label Image

Norgestimate Fig8

FDA Label Image

Norgestimate Fig9

Norgestimate Fig9
Tri-Lo-Mili is a set of oral contraceptives in the form of tablets used to prevent pregnancy. The product comes in three variations: one with 0.180mg/0.025mg, another with 0.215mg/0.025mg, and the last with 0.250mg/0.025mg of norgestimate and ethinyl estradiol tablets USP, respectively. Pharmaceutical company Aurobindo distributes the product which comes with a patient information leaflet in each carton. It is essential to note that Tri-Lo-Mili does not protect against HIV infection or other sexually transmitted diseases. The recommended dosage of the tablet is one each day. Store the product at a temperature range of 20° to 25°C (68° to 77°).*
FDA Label Image

Chemical Structure (Norgestimate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.